文献速递鼻科

术前Lund-Mackay CT评分与慢性鼻窦炎症状严重度及术后生活质量轨迹相关

Preoperative Lund-Mackay computed tomography score is associated with preoperative symptom severity and predicts quality-of-life outcome trajectories after sinus surgery.
PubMed 文献 · Int Forum Allergy Rhinol · 2018-03-08

结果显示术前LMCTS与术前及术后SNOT-22评分显著相关,且术前LMCTS最高四分位患者术后SNOT-22改善最大(29.9分),最低四分位改善最小(16.8分),两组12个月变化差13.1分。

要点

  • 术前LMCTS与术前SNOT-22评分显著相关(p<0.01),主要由鼻外和鼻科子域驱动。
  • 术前LMCTS最高四分位患者FESS术后12个月SNOT-22改善最大(29.9分,95%CI 24.9-34.8)。
  • 术前LMCTS最低四分位患者12个月SNOT-22平均变化最小(16.8分,95%CI 12.2-21.3)。

核心结论

  • 术前LMCTS与药物难治性慢性鼻窦炎患者术前鼻外和鼻科症状严重度相关。
  • 术前LMCTS可指示FESS术后生活质量结局轨迹,高评分者改善更明显。

研究设计与样本

  • 收集术前LMCTS及术前和术后12个月SNOT-22评分,采用纵向线性混合效应模型分析。

主要发现

  • 术前LMCTS与术前SNOT-22评分显著相关(p<0.01),与术后SNOT-22评分也显著相关(p<0.001)。
  • 术前LMCTS最低四分位患者12个月SNOT-22平均变化16.8分(95%CI 12.2-21.3)。
  • 术前LMCTS第二和第三低四分位患者12个月SNOT-22平均变化分别为21.1分(95%CI 16.7-25.4)和23.1分(95%CI 18.3-27.9)。
  • 术前LMCTS最高四分位患者12个月SNOT-22平均变化29.9分(95%CI 24.9-34.8)。
  • 最高与最低四分位12个月SNOT-22变化差13.1分(95%CI 6.0-20.2;p<0.001)。

临床怎么用

  • 术前LMCTS可用于评估药物难治性慢性鼻窦炎患者术前症状严重度并预测FESS术后生活质量改善程度。
  • 术前LMCTS较高的患者可能从FESS中获得更大的生活质量改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disagreement exists about the relationship between Lund-Mackay CT scores (LMCTS) and quality-of-life outcome (QoL) measures. We investigated whether preoperative LMCTS are associated with preoperative QoL, and whether LMCTS is predictive of postoperative QoL outcomes in chronic rhinosinusitis (CRS) patients. METHODS: Adult patients with medically recalcitrant CRS (n = 665) were enrolled in a prospective, observational cohort study. Preoperative LMCTS and pre- and postoperative self-reported QoL outcomes (22-item Sino-Nasal Outcomes Test [SNOT-22]) were collected and evaluated over 12 months. Five hundred sixty-eight patients met the inclusion criteria. Longitudinal linear mixed-effects modeling was used to investigate the effect of LMCTS on QoL after functional endoscopic sinus surgery (FESS). RESULTS: Preoperative LMCTS were significantly associated with preoperative SNOT-22 scores (p < 0.01) and postoperative SNOT-22 scores (p < 0.001), driven by Extranasal and Rhinologic subdomains of the QoL questionaire. Patients in the lowest preoperative LMCTS quartile had the lowest mean change in SNOT-22 scores at 12 months (16.8 points; 95% confidence interval [CI], 12.2-21.3). Patients in the second and third lowest preoperative LMCTS quartiles had mean changes at 12 months of 21.1 points (95% CI, 16.7-25.4) and 23.1 points (95% CI, 18.3-27.9). Patients in the highest preoperative LMCTS quartile had the greatest improvement in SNOT-22 scores after FESS (29.9 points; 95% CI, 24.9-34.8). The difference in QoL change at 12 months between the highest and lowest preoperative LMCTS quartiles was 13.1 points (95% CI, 6.0-20.2; p < 0.001). CONCLUSION: Our study demonstrates that preoperative LMCTS correlate with preoperative extranasal and rhinologic symptom severity and that the LMCTS is an indicator of postsurgical QoL outcomes for medically recalcitrant chronic rhinosinusitis patients in a large tertiary otolaryngology setting.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Brooks SG, Trope M, Blasetti M, et al. Preoperative Lund-Mackay computed tomography score is associated with preoperative symptom severity and predicts quality-of-life outcome trajectories after sinus surgery. Int Forum Allergy Rhinol. 2018. PMID: 29517156. doi:10.1002/alr.22109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。